Pathophysiologic and treatment strategies for cardiovascular disease in end-stage renal disease and kidney transplantations.
about
Metabolic consequences of modern immunosuppressive agents in solid organ transplantationCardiovascular risk factors following renal transplantCharacterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients.Rationale and study design of the prospective, longitudinal, observational cohort study "rISk strAtification in end-stage renal disease" (ISAR) studyIdentification of expanded T-cell clones by spectratyping in nonfunctioning kidney transplants.Associations of genetic variants of endothelin with cardiovascular complications in patients with renal failure.
P2860
Pathophysiologic and treatment strategies for cardiovascular disease in end-stage renal disease and kidney transplantations.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Pathophysiologic and treatment ...... e and kidney transplantations.
@en
type
label
Pathophysiologic and treatment ...... e and kidney transplantations.
@en
prefLabel
Pathophysiologic and treatment ...... e and kidney transplantations.
@en
P2093
P1433
P1476
Pathophysiologic and treatment ...... e and kidney transplantations.
@en
P2093
Belinda Jim
Mark Kozicky
Mythili Ghanta
P304
P356
10.1097/CRD.0000000000000044
P577
2015-05-01T00:00:00Z